Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | D. Wang et al., Mol. Pharmacol., Jun 2005; 67: 2173 - 2184 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Zuo et al., J. Virol., Feb 2011; 85: 1604 - 1614 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Scherer et al., ImmunoHorizons , 2018, 2(10): 324-337; doi.org/10.4049/immunohorizons.1800065 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | T. R. H. Büch et al., J. Biol. Chem., Sep 2009; 284: 26411 - 26420 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Scherer et al., Dev. Comp. Immunol., 2018, 82 :128-138, doi: 10.1016/j.dci.2018.01.014 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Iyori et al., Antimicrob. Agents Chemother., Jan 2008; 52: 121 - 127 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. Neuhofer et al., Frontiers in Physiol., 5 , article 123, doi: 10.3389/fphys.2014.00123 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | H. J. Solinski et al., Mol. Pharmacol., Aug 2010; 78: 249 - 259 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. de Araujo Brasil et al., PNAS, 2019, 116, 51: 25991–26000, doi/10.1073/pnas.1902483116 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | B. C. Viertlboeck et al., J. Immunol., Jun 2009; 182: 6985 - 6992 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Haar et al., Nucleic Acids Res., Feb 2016; 44: 1326 - 1341 | Link | |
HEK293 EBNA1 |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen 1 (EBNA1) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. T. Hellwig et al., J. Biol. Chem., Aug 2008; 283: 21676 - 21685 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S.-B. M. Varda et al., 2012, WO 2007/043049 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. de la Fuente et al., Biochem. J., 2014, 458: 33-40, doi:10.1042/BJ20131025 | ||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J.-S. Kim et al., Cancer Biol. & Ther., 2012, 13: 1307–1318, doi.org/10.4161/cbt.21788 | Link | |
hRPEC |
Human retinal pigment epithelial cells | Human | sensory organs | primary cell | adherent | siRNA | stable transfection | Metafectene | publication | I-Ta Lee et al., PLoS ONE 10(2): e0117911. doi:10.1371/journal.pone.0117911 | Link | ||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
iPSCs |
Mouse induced pluripotent stem cells | Mouse | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene | publication | J. Kuehle et al., Mol. Therapy, 2014, 22(5) :919-928, doi:10.1038/mt.2014.4 | Link | ||
L cells |
Mouse subcutaneous connective tissue fibroblast cell line | ATCC CRL-2648 | Mouse | other | cell line | adherent | plasmid | stable transfection | Metafectene | publication | V. J. Jokubaitis et al., Blood, Apr 2008; 111: 4055 - 4063 | Link | |
Lec1 |
Chinese hamster ovary cell line | ATCC CRL-1735 | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Altamirano et al., J. Proteome Res., 2018, 17: 1269−1277, DOI:10.1021/acs.jproteome.7b00867 | ||
LLC-PK1 |
Swine kidney ephitelial cell line | ATCC CL-101 | Swine | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
LM16-R |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Eriomina, thesis, 2020, The Open University, doi.org/10.21954/ou.ro.00011212 | Link |